U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H25NO2
Molecular Weight 263.3752
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYCLEXANONE

SMILES

O=C1CCCC1(CCN2CCOCC2)C3=CCCC3

InChI

InChIKey=KUOYUNPLUMKQIF-UHFFFAOYSA-N
InChI=1S/C16H25NO2/c18-15-6-3-7-16(15,14-4-1-2-5-14)8-9-17-10-12-19-13-11-17/h4H,1-3,5-13H2

HIDE SMILES / InChI
Molecular Formula C16H25NO2
Molecular Weight 263.3752
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Cyclexanone is an antitussive drug developed by the Swiss pharmaceutical company Ciba. The compound is claimed to have an analgesic action and an action on central respiratory control.

Approval Year

Unknown
139594
Patents

Patents

JPS5763445A
1
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:20:48 GMT 2023
Edited
by admin
on Sat Dec 16 17:20:48 GMT 2023
Record UNII
2OU4KS37EO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CYCLEXANONE
INN   MI  
INN  
Official Name English
2-(CYCLOPENT-1-ENYL)-2-(2-MORPHOLINOETHYL)CYCLOPENTANONE
Systematic Name English
CYCLEXANONE [MI]
Common Name English
CYCLOPENTANONE, 2-(1-CYCLOPENTEN-1-YL)-2-(2-(4-MORPHOLINYL)ETHYL)-
Systematic Name English
cyclexanone [INN]
Common Name English
PENTETHYLCYCLANONE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66917
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
Code System Code Type Description
INN
1799
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
MERCK INDEX
m672
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY Merck Index
SMS_ID
100000083728
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
WIKIPEDIA
Pentethylcyclanone
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
EVMPD
SUB06845MIG
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
FDA UNII
2OU4KS37EO
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
CAS
15301-52-7
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
EPA CompTox
DTXSID50934664
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
PUBCHEM
10355398
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104110
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
NCI_THESAURUS
C78108
Created by admin on Sat Dec 16 17:20:48 GMT 2023 , Edited by admin on Sat Dec 16 17:20:48 GMT 2023
PRIMARY
Related Record Type Details
Structure of CYCLEXANONE, (S)-
ENANTIOMER -> RACEMATE
Structure of CYCLEXANONE, (R)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of CYCLEXANONE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966